#als-treatment

[ follow ]
#drug-market-withdrawal

Lots of drug companies talk about putting patients first but this one actually did

Key Takeaway: Amylyx Pharmaceuticals voluntarily pulled their ALS drug from the market after a study revealed it wasn't effective, demonstrating commitment to integrity and ethics.

$158,000 ALS drug pulled from market after failing in large clinical trial

The drug Relyvrio, approved for ALS treatment, did not show benefits in a clinical trial and is being pulled from the market.
The FDA approved Relyvrio despite shaky data, and the drug's failure highlights the need for more effective ALS treatments.

Lots of drug companies talk about putting patients first but this one actually did

Key Takeaway: Amylyx Pharmaceuticals voluntarily pulled their ALS drug from the market after a study revealed it wasn't effective, demonstrating commitment to integrity and ethics.

$158,000 ALS drug pulled from market after failing in large clinical trial

The drug Relyvrio, approved for ALS treatment, did not show benefits in a clinical trial and is being pulled from the market.
The FDA approved Relyvrio despite shaky data, and the drug's failure highlights the need for more effective ALS treatments.
moredrug-market-withdrawal

A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market

FDA-approved ALS treatment Relyvrio failed a large clinical trial.
Results showed the treatment did not work better than a placebo.
[ Load more ]